Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TYMS | P04818 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PGK1 | P00558 | 2/20 | 0.33 |
| ▸ | PGK2 | P07205 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9126 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL8851940 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL1332284 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL897840 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL22 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL8844890 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL3788505 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL5907 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL36090 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL45358 | 1.00 | CA2 (0.56) | CA2SLC34A1FDPSBLMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1874 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085168-A1 | PLANT FIBRE PRODUCT | Beyondwood Coöperation U.A. (NL) | 2026-03-26 | — | — | US | claimed |
| US-12467085-B2 | High accuracy nanopore-based single molecule sequencing by synthesis with tagged nucleotides | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-11-11 | — | — | US | claimed |
| EP-4587503-A1 | PLANT FIBRE PRODUCT | Beyondwood Coöperation U.A. (NL) | 2025-07-23 | — | — | EP | claimed |
| US-20250222132-A1 | NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2025-07-10 | — | — | US | claimed |
| WO-2025133105-A1 | COMPOSITIONS AND METHODS | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2025-06-26 | — | — | WO | claimed |
| CN-114846149-B | Methods and kits for template independent nucleic acid synthesis | 陈呈尧 | 2025-06-10 | — | — | CN | claimed |
| US-20250169521-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE PALATABILITY OF DRY PET FOOD | Société des Produits Nestlé S.A. (CH) | 2025-05-29 | — | — | US | claimed |
| EP-4504158-A1 | NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2025-02-12 | — | — | EP | claimed |
| EP-3699271-B1 | GRANULE AND PELLET COMPOSITIONS COMPRISING PHYTASE AND PHYTIC ACID AND PREPARATION METHOD | DANISCO US INC (US) | 2024-09-25 | — | — | EP | claimed |
| US-20240158425-A1 | MODIFIED ADENINES | NUCLERA LTD (GB) | 2024-05-16 | — | — | US | claimed |
| US-4728165-A | Superimposed fast transient and permanent holographic gratings | RESEARCH CORPORATION (US) | 1988-03-01 | — | — | US | claimed |
| US-4713327-A | SUPPORT, REGISTRATION, AND ISOTROPIC POROUS SPREADING LAYER | EASTMAN KODAK COMPANY (US) | 1987-12-15 | — | — | US | claimed |
| EP-0101341-B1 | PROCESS AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR HEMOGLOBIN ALLOSTERIC EFFECTORS, AND ERYTHROCYTES SO OBTAINED | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-11-05 | — | — | EP | claimed |
| EP-0022757-B1 | METHOD FOR DETERMINING CREATINE KINASE IN SAMPLES CONTAINING ATP | LKB-Produkter AB (SE) | 1984-09-19 | — | — | EP | claimed |
| EP-0101341-A1 | Process and device for the encapsulation in erythrocytes of at least one biologically active substance, in particular hemoglobin allosteric effectors, and erythrocytes so obtained | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1984-02-22 | — | — | EP | claimed |
| EP-0015437-B1 | METHOD AND REAGENT FOR THE DETERMINATION OF CREATINE KINASE | Roche Diagnostics GmbH (DE) | 1981-11-25 | — | — | EP | claimed |
| EP-0008341-B1 | METHOD AND REAGENT FOR ENZYMATIC DETERMINATIONS AND TEST KIT FOR THIS METHOD | Roche Diagnostics GmbH (DE) | 1981-11-04 | — | — | EP | claimed |
| EP-0001104-B1 | MODIFIED INTACT ERYTHROCYTES, BLOOD OR BLOOD PRESERVES CONTAINING THEM AND PROCESS FOR THEIR PREPARATION | Studiengesellschaft Kohle mbH (DE) | 1981-05-20 | — | — | EP | claimed |
| US-4249141-A | Laser systems using pentaphosphate active mediums | UNIVERSITY OF ROCHESTER (US) | 1981-02-03 | — | — | US | claimed |
| US-4195226-A | Luminescent material and preparation and use thereof | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1980-03-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085168-A1 | PLANT FIBRE PRODUCT | PRRC2C, SYMPK, PIP5K1C | CA2 599/4885SLC34A1 1565/4885FDPS 319/4885 |
| US-20250222132-A1 | NUCLEIC ACID COMPOSITIONS COMPRISING A MULTIVALENT ANION, SUCH AS AN INORGANIC POLYPHOSPHATE, AND METHODS FOR PREPARING, STORING AND USING THE SAME | NSUN3, RNGTT, SNRPA1 | CA2 1776/4885SLC34A1 232/4885FDPS 2580/4885 |
| US-20240158425-A1 | MODIFIED ADENINES | RNGTT, ADAR, MRM1 | CA2 2729/4885SLC34A1 1351/4885FDPS 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.